Homeβ€ΊSearchβ€ΊBrain Tumor Pathology

Brain Tumor Pathology

Springer Japan Β· Japan Β· Est. 1989

ISSN1433-7398eISSN1861-387X
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJR
90
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (2 more)+12
Total90
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
154
days submission β†’ published
measured Β· last 20 articles Β· accept 142d
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.623
H-Indexi
54
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.759
Total Worksi
840
Total Citationsi
15,002
2yr Mean Citednessi
1.03
Open Impact Factor alternative

Aims & Scope

This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics.Review articles and Topics may be recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions should be aimed at promoting international scientific collaboration.

General Information

Country / RegionJapan
Primary LanguageEnglish
1st Year Published1989
FrequencyFour No. A Year, 2011-
StatusActive (last: 2026)
Total Publications840
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Springer Japan
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1433-7398 / 1861-387X
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
24
515
2019
32
626
2020
30
396
2021
30
300
2022
27
175
2023
19
61
2024
28
17
2025
22
0
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Medicine (miscellaneous)Q2
Cancer ResearchQ3
Neurology (clinical)Q3
OncologyQ3

Subject Classification

Web of Science Categories

Clinical NeurologyOncologyPathology

Scopus Categories

Neurology (clinical)Cancer ResearchOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Glioma Diagnosis and TreatmentMeningioma and schwannoma managementNeurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsBrain Metastases and TreatmentSarcoma Diagnosis and TreatmentChromatin Remodeling and CancerVascular Malformations Diagnosis and TreatmentPituitary Gland Disorders and TreatmentsCNS Lymphoma Diagnosis and Treatment

Frequently asked questions about Brain Tumor Pathology

Is Brain Tumor Pathology a predatory journal?

PubScope has no integrity flags on record for Brain Tumor Pathology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Brain Tumor Pathology?

Brain Tumor Pathology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.03.

Is Brain Tumor Pathology indexed in Scopus and Web of Science?

Brain Tumor Pathology is indexed in Web of Science, Scopus.

What is the aims and scope of Brain Tumor Pathology?

This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics.Review articles and Topics may be recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref